DocGo (DCGO) Competitors

DocGo (NASDAQ:DCGO) and Aveanna Healthcare (NASDAQ:AVAH) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, community ranking, media sentiment, analyst recommendations, profitability and dividends.

Does the media favor DCGO or AVAH?

In the previous week, DocGo had 1 more articles in the media than Aveanna Healthcare. MarketBeat recorded 4 mentions for DocGo and 3 mentions for Aveanna Healthcare. DocGo's average media sentiment score of 1.71 beat Aveanna Healthcare's score of 0.53 indicating that DocGo is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DocGo	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Aveanna Healthcare	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders have more ownership in DCGO or AVAH?

56.4% of DocGo shares are owned by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are owned by institutional investors. 2.7% of DocGo shares are owned by company insiders. Comparatively, 7.8% of Aveanna Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Is DCGO or AVAH more profitable?

DocGo has a net margin of 4.35% compared to Aveanna Healthcare's net margin of -3.32%. DocGo's return on equity of 8.90% beat Aveanna Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DocGo	4.35%	8.90%	5.72%
Aveanna Healthcare	-3.32%	N/A	-0.89%

Does the MarketBeat Community believe in DCGO or AVAH?

DocGo received 23 more outperform votes than Aveanna Healthcare when rated by MarketBeat users. Likewise, 75.00% of users gave DocGo an outperform vote while only 36.76% of users gave Aveanna Healthcare an outperform vote.

Company	Underperform	Outperform
DocGo	Outperform Votes 48 75.00%	Underperform Votes 16 25.00%
Aveanna Healthcare	Outperform Votes 25 36.76%	Underperform Votes 43 63.24%

Which has stronger earnings & valuation, DCGO or AVAH?

DocGo has higher earnings, but lower revenue than Aveanna Healthcare. Aveanna Healthcare is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DocGo	$616.56M	0.37	$6.86M	$0.17	13.12
Aveanna Healthcare	$2.02B	0.44	-$134.52M	-$0.07	-65.86

Do analysts rate DCGO or AVAH?

DocGo presently has a consensus target price of $4.89, suggesting a potential upside of 119.36%. Aveanna Healthcare has a consensus target price of $5.00, suggesting a potential upside of 8.46%. Given DocGo's stronger consensus rating and higher possible upside, equities research analysts plainly believe DocGo is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DocGo	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83
Aveanna Healthcare	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Which has more volatility & risk, DCGO or AVAH?

DocGo has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 1.99, meaning that its share price is 99% more volatile than the S&P 500.

Summary

DocGo beats Aveanna Healthcare on 13 of the 18 factors compared between the two stocks.